ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 982

Genetic Variants near Insulin-Like Growth Factor Binding Protein 3 (IGFBP3) Are Associated with Hip Osteoarthritis

Daniel S. Evans1, Neeta Parimi1, Ana M. Valdes2, Hanneke J.M Kerkhof3, Frederic Cailotto4, Michael C. Nevitt5, Steven R. Cummings1, Rik J. Lories6, Timothy D. Spector7, Nigel K. Arden8, Joyce B. van Meurs3 and Nancy E. Lane9, 1California Pacific Medical Center Research Institute, San Francisco, CA, 2Department of Twin Research and Genetic Epidemiology, Dept of Twin Research and Genetic Epidemiology, St. Thomas' Hospital, King's College London, London, United Kingdom, 3Department of Internal Medicine, Erasmus Medical Center and The Netherlands Genomics Initiative-Sponsored Netherlands Consortium for Healthy Aging, Rotterdam, Netherlands, 4Laboratory for Skeletal Development and Joint Disorders, Department of Development and Regeneration, KU Leuven, Leuven, Belgium, 5Epidemiology & Biostatistics, UCSF (University of California, San Francisco), San Francisco, CA, 6Dept of Development and Regeneration, Laboratory for Skeletal Development and Joint Disorders, KU Leuven, Leuven, Belgium, 7Dept of Twin Research and Genetic Epidemiology, King's College London, London, United Kingdom, 8NDORMS; MRC Lifecourse Epidemiology Unit, Oxford NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, United Kingdom, 9Internal Medicine, Center for Musculoskeletal Health, UC Davis School of Medicine, Sacramento, CA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: genomics, insulin-like growth factor and osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Genetics and Genomics of Rheumatic Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose: Hip osteoarthritis (HOA) is one of the most common joint disorders and can result in pain and disability.  HOA is heritable, but the particular genes contributing to the development of HOA are not well defined.  To identify genetic associations with HOA, we conducted a two-stage genome-wide association study (GWAS).

Methods: All analyses were restricted to individuals of European ancestry.  The discovery phase was performed using radiographically determined HOA cases and controls selected from the Osteoporotic Fractures in Men (MrOS) Study and the Study of Osteoporotic Fractures (SOF) (combined cases = 662).  HOA cases were defined as Croft grade ≥ 2 or total hip replacement (THR).  HOA controls were defined as Croft grade ≤ 1, maximum joint space narrowing (JSN) ≤ 1, maximum osteophytes ≤ 1, and no THR.  SNPs were genotyped using the Illumina Omni1-Quad array and approximately 2.5 million SNPs were imputed using the HapMap reference panel.  Logistic regression was performed, and MrOS and SOF results were combined using inverse variance weighted fixed effect meta-analysis.  SNP associations with P-values ≤ 5×10-8were examined for replication in the Rotterdam cohorts (RSI = original cohort, RSII = second recruitment cycle), Twins UK, and Chingford cohorts.  Publicly available eQTL data from HapMap CEU lymphoblastoid cell lines were used.

Results:

On average, MrOS participants (100% male) were older than SOF participants (100% female) at the clinic visits when HOA was assessed (MrOS: mean±SD = 77.5±5.4 years, range = 69-97; SOF: mean±SD = 70.9±5.0 years, range = 65-91).  In the discovery meta-analysis, the rs788748 A allele and the rs879966 G allele were associated with decreased odds for HOA (Table 1).  The two directly genotyped SNPs were 23 kb apart and were in moderate LD (HapMap CEU r2= 0.54).  Neither SNP remained nominally significant in conditional analysis, indicating dependence.  The SNP rs788748 replicated in the RSI cohort, but not the RSII cohort or the Chingford cohort.  In the Twins UK cohort, the association between the rs788748 A allele and HOA was significant and in the opposite direction relative to the discovery samples (Table 1).  The SNP rs879966 did not replicate (Table 1). 

Table 1.  SNP association results in discovery and replication cohorts.

SNP

Effect

allele

(Freq)

MrOS/SOF

(discovery)

RSI

RSII

Twins UK

Chingford

 

 

cases/

controls

OR

(P)

cases/

controls

OR

(P)

cases/

controls

OR

(P)

cases/

controls

OR

(P)

cases/

controls

OR

(P)

rs788748

A

(0.49)

662/

4750

0.71

(3×10-8)

462/

3428

0.86

(0.03)

149/

1430

1.02

(0.86)

73/

366

1.48

(0.03)

83/

492

1.11

(0.54)

rs879966

G

(0.39)

662/

4750

0.70

(2×10-8)

462/

3428

0.92

(0.24)

149/

1430

1.12

(0.38)

73/

366

1.34

(0.10)

83/

492

1.00

(0.99)

From eQTL data, rs788748 and rs879966 were marginally associated with IGFBP3 expression (P-value = 0.07 and 0.06, respectively), but not IGFBP1 expression (P-value = 0.74 and 0.34, respectively).  SNP associations with circulating IGFBP3 levels and results from IGFBP3 knockdown experiments in the ATDC5 chondrogenesis model system will be presented.

Conclusion: Our genetic association and eQTL results provide suggestive evidence for a link between IGFBP3 and HOA, but further replication is required for the association results to be considered robust.  IGFBP3 is known to be expressed in human chondrocytes and might be an attractive candidate for follow-up studies.


Disclosure:

D. S. Evans,
None;

N. Parimi,
None;

A. M. Valdes,
None;

H. J.M Kerkhof,
None;

F. Cailotto,
None;

M. C. Nevitt,
None;

S. R. Cummings,
None;

R. J. Lories,
None;

T. D. Spector,
None;

N. K. Arden,
None;

J. B. van Meurs,
None;

N. E. Lane,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/genetic-variants-near-insulin-like-growth-factor-binding-protein-3-igfbp3-are-associated-with-hip-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology